197145-37-2

Usage

Uses

Used in Chemical Research:
3-(Dimethylamino)-1-(3-methoxyphenyl)-2-methyl-1-propanone is used as a research compound for exploring its chemical properties and reactivity. Its diverse functional groups make it a valuable candidate for studying reaction mechanisms and potential applications in the synthesis of new compounds.
Used in Pharmaceutical Industry:
3-(Dimethylamino)-1-(3-methoxyphenyl)-2-methyl-1-propanone is used as a starting material or intermediate in the synthesis of pharmaceutical compounds. Its unique structure may contribute to the development of new drugs with novel therapeutic properties.
Used in Material Science:
3-(Dimethylamino)-1-(3-methoxyphenyl)-2-methyl-1-propanone is used as a component in the development of new materials with specific properties. Its electronic configuration and polarity may play a role in the creation of advanced materials for various applications, such as electronics or coatings.
Used in Industrial Applications:
3-(Dimethylamino)-1-(3-methoxyphenyl)-2-methyl-1-propanone is used as a specialty chemical in various industrial processes. Its potential reactivity and solubility behaviors could be harnessed for the production of specific industrial chemicals or materials.

InChI:InChI=1/C13H19NO2/c1-10(9-14(2)3)13(15)11-6-5-7-12(8-11)16-4/h5-8,10H,9H2,1-4H3

Upstream product

• 37951-53-4 3-(dimethylamino)-1-(3-methoxyphenyl)-2-methylpropan-1-one hydrochloride 
• 50-00-0 formaldehyd 
• 37951-49-8 1-(3-methoxyphenyl)propan-1-one 
• 506-59-2 N,N-dimethylammonium chloride 
• 51-80-9 bis-(dimethylamino)methane 
• 3027-13-2 1-(3-methoxyphenyl)propan-2-one 

Downstream Products

• 1217854-15-3 (R)-3-(dimethylamino)-1-(3-methoxyphenyl)-2-methylpropan-1-one 
• 850222-41-2 (S)-3-(dimethylamino)-1-(3-methoxyphenyl)-2-methylpropan-1-one (2R,3R)-O,O'-dibenzoyltartrate 
• 213257-55-7 (2RS)-3-dimethylamino-1,1-bis-(3-methoxy-phenyl)-2-methyl-propan-1-ol hydrochloride 
• 175590-76-8 (2RS,3RS)-1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol 
• 175591-09-0 tapentadol hydrochloride 
• 175591-23-8 tapentadol 
• 175591-22-7 (βR,γR)-γ-ethyl-N,N,β-trimethyl-3-methoxybenzenepropanamine 
• 175590-76-8 (2SS,3RS)-[3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol]-dimethylamine 
• 850222-40-1 (2S)-3-dimethylamino-1-(3-methoxyphenyl)-2-methyl-1-propanone 
• 1314003-88-7 (R,R)-tapentadol-(PABA tert-butyl ester) carbamate 
• 1314003-30-9 (R,R)-tapentadol-PABA carbamate trifluoroacetate 
• 809282-29-9 3-(3-methoxyphenyl)-N,N,2-trimethylpent-3-en-1-amine 

Relevant academic research and scientific papers

A NOVEL PROCESS FOR THE PREPARATION OF 1-PHENYL-3-AMINOPROPANE DERIVATIVES

The present invention relates to a novel process for the preparation of 1-phenyl-3- aminopropane derivative compounds corresponding to the formula (I) and/or its intermediates, and/or its stereo specific isomers or pharmaceutically acceptable salts, hydra

PRODRUGS OF OPIOIDS AND USES THEREOF

The present invention concerns prodrugs of opioid analgesics and pharmaceutical compositions containing such prodrugs. Methods for providing more consistent pain relief by increasing the bioavailability of the opioid analgesic with the aforementioned prodrugs are provided. The invention also provides for decreasing the adverse GI side effects of opioid analgesics.

AMINO ACID AND PEPTIDE CARBAMATE PRODRUGS OF TAPENTADOL AND USES THEREOF

Prodrugs of tapentadol with amino acids or short peptides, pharmaceutical compositions containing such prodrugs and a method for providing pain relief with the tapentadol prodrugs are provided herein. Prodrugs having side chains of valine, leucine, isoleucine and glycine amino acids and mono-, di- and tripeptides thereof are preferred. Additionally, methods for avoiding or minimizing the adverse gastrointestinal side effects associated with tapentadol administration, as well as increasing the oral bioavailability of tapentadol are provided herein.

PREPARATION OF (2R,3R)-3-(3-METHOXYPHENYL)-N,N,2-TRIMETHYLPENTANAMINE

The present invention relates to an improved process for the preparation of (2R,3R)-3- (3-methoxyphenyl)-N,N,2-trimethylpentanamine which is an intermediate for the preparation of the analgesic tapentadol.

PROCESS FOR THE PREPARATION OF (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL

The present invention relates to a process for the preparation of (1 R,2R)-3- dimethylamino-1-ethyl-2-methyl-propyl)-phenol.

Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients

Dimethyl-(3-aryl-but-3-enyl)-amine compounds, a method of preparing them, and the use of the compounds as pharmaceutical active ingredients are described.